Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
Mara A Schonberg, Edward R Marcantonio, Donglin Li...
https://pubmed.ncbi.nlm.nih.gov/20308658/Actively Recruiting
Led by Beth Israel Deaconess Medical Center · Updated on 2026-04-07
402
Participants Needed
11
Research Sites
52 weeks
Total Duration
Researchers are conducting a cluster randomized clinical trial to evaluate a multi-level intervention involving shared decision making training for breast surgeons and a patient decision aid for women aged 70 and older with low-risk Stage I breast cancer. This study aims to improve treatment decisions and outcomes by supporting communication between surgeons and older women facing breast cancer treatment choices. The trial is being conducted across seven large health systems in the U.S. The intervention includes a one-hour shared decision making training for surgeons and providing eligible patients with a tailored decision aid before their first surgical visit. Surgeons randomized to the intervention arm receive training via live televideo or video recording and ongoing support including access to decision tools and feedback on challenging cases. Patients receive the decision aid by mail, email, or patient portal. Surgeons in the usual care arm continue their standard treatment discussions without additional support. The study plans to recruit 44 surgeons and over 1,100 women over three years. Participants will be observed through medical record reviews to determine treatments received and outcomes such as breast cancer recurrence and survival over 6 months to 3.5 years. Patients and caregivers will complete surveys at one week and six months after the initial surgical visit to report on shared decision making quality, knowledge, decisional conflict, quality of life, and treatment satisfaction. Surgeons will complete baseline and end-of-study surveys, with some participating in interviews to provide feedback. The study will also assess healthcare costs and the feasibility of implementing the intervention in clinical practice.
CONDITIONS
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
M
Mara Schonberg, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Beth Israel Deaconess Medical Center
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Surgeon SDM training + decision aid | Standard-of-care consultation |
|---|---|---|
| What it is | Patients meet with a surgeon who has received shared decision-making training. Before their surgical visit, they receive a personalized decision aid about breast cancer treatment options. | Patients receive usual surgical consultation and information as provided in standard clinical practice, with no additional SDM training for the surgeon or access to a tailored decision aid. |
| Role in the study | Assess if shared decision-making tools improve patient outcomes in older women considering treatment for low-risk early breast cancer. | Serves as the comparison group, representing the usual decision-making approach for treatment choice. |
| Primary use | To help patients and surgeons make treatment decisions together, supporting informed choices about surgery and other treatments. | Facilitates treatment planning for breast cancer using the surgeon's usual consultation methods. |
| How it is delivered or performed | Surgeons are trained in shared decision-making. Patients receive a decision aid personalized to their diagnosis to review before meeting with the surgeon. | Patients attend their surgical consultation and receive advice, information, and recommendations according to each surgeon's standard approach. |
| Evidence status | Ongoing trial; published studies show decision aids improve patients’ understanding, engagement, and satisfaction, and may reduce decisional conflict. Evidence among older women with early breast cancer supports the acceptability and likely usefulness of decision aids. | Usual practice is widespread and based on clinical guidelines. Without structured SDM tools, patients may be less engaged and experience more uncertainty about choices. |
| Important limitations | Decision aids are not tailored to every patient scenario, and relying on them may not fully substitute for individual medical advice. Not all patients may wish to use decision aids. | Standard care without SDM tools may lead to patients receiving less information, feeling less involved, or experiencing greater uncertainty about their treatment options. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for initial surgical consultation
Duration - Up to 8 weeks before patient surgical encounter
Surgeons in the intervention arm complete a 1-hour training in shared decision making and provide eligible patients with a tailored breast cancer treatment decision aid before the initial surgical consultation. Patients receive the decision aid via mail, email, or patient portal to support treatment discussions with their surgeon.
Surgeons have 1 training session; patients have 1 surgical consultation visit
Duration - 6 months
Patients or their caregivers complete surveys at approximately 1 week and 6 months after their initial surgical encounter to report on shared decision making quality, knowledge, decisional conflict, quality of life, treatment decisions, and healthcare utilization.
2 surveys (1 week and 6 months post-surgery) completed in person, by phone, or online
Duration - Up to 3.5 years
Research assistants review medical records to assess treatments received within 6 months of the initial surgical visit and to monitor patient outcomes including recurrence and survival for up to 3.5 years.
No visits required; data collected from medical records
Duration - Up to 4 years
Surgeons complete baseline and end-of-study surveys about their confidence and attitudes toward shared decision making. Intervention arm surgeons receive ongoing feedback and newsletters. Usual care surgeons may receive training after the study ends.
Multiple surveys and possible virtual training sessions; interviews for select surgeons
Duration - At 12 months and at study end
Selected patients, caregivers, surgeons, administrators, and allied health professionals participate in interviews at 12 months and at the end of the study to provide feedback on the intervention and its implementation.
Interviews conducted by phone, in-person, or virtually
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Mara A Schonberg, Edward R Marcantonio, Donglin Li...
https://pubmed.ncbi.nlm.nih.gov/20308658/Mara A Schonberg, Edward R Marcantonio, Long Ngo...
https://pubmed.ncbi.nlm.nih.gov/22368726/Roberto Gennari, Giuseppe Curigliano, Nicole Rotmensz...
https://pubmed.ncbi.nlm.nih.gov/15316944/Anthony W Fyles, David R McCready, Lee A Manchul...
https://pubmed.ncbi.nlm.nih.gov/15342804/Ian H Kunkler, Linda J Williams, Wilma J L Jack...
https://pubmed.ncbi.nlm.nih.gov/25637340/Leigh Simmons, Lauren Leavitt, Alaka Ray...
https://pubmed.ncbi.nlm.nih.gov/27064722/S G Diab, R M Elledge, G M Clark
https://pubmed.ncbi.nlm.nih.gov/10749910/Mara A Schonberg, Maria Karamourtopoulos, Alicia R Jacobson...
https://pubmed.ncbi.nlm.nih.gov/32793815/Petra Falkenbach, Aleksi J Raudasoja, Robin W M Vernooij...
https://pubmed.ncbi.nlm.nih.gov/37605243/Gregory Bruce Mann, Anita Rohini Skandarajah, Nicholas Zdenkowski...
https://pubmed.ncbi.nlm.nih.gov/38065194/Beth Israel Deaconess Medical Center
Lead Sponsor